Ion Storage Systems
Series A in 2024
Ion Storage Systems, LLC is a manufacturer of solid-state lithium-ion batteries, established in 2015 and based in College Park, Maryland. The company focuses on developing high-energy-density and safe batteries suitable for diverse applications, including defense and aerospace, consumer electronics, and electric vehicles. Ion Storage Systems has made significant advancements in solid-state battery technology, creating products that address the mission-critical needs of the defense sector while also enhancing safety and efficiency for consumer electronics and electric vehicles. Their innovative battery design features a unique structure that utilizes non-flammable materials, ensuring safety, lightness, and compactness for various applications.
Bionaut Labs
Series B in 2024
Bionaut Labs, established in 2016 and based in Palo Alto, California, specializes in the design, manufacture, and control of intra-tissue navigation platforms. The company's core technology involves nano/micro robots, dubbed 'Bionauts', which operate within the body to deliver treatments with anatomical precision. Bionaut Labs aims to revolutionize the treatment of central nervous system disorders by enabling new therapeutic technologies like gene therapy and CRISPR-Cas9 in challenging clinical settings. Their remote-controlled micro-robots allow for precise targeting, tracking, and payload release, potentially automating complex surgeries remotely without external incisions.
Nanochon
Seed Round in 2024
Nanochon is a medical device company focused on developing innovative solutions for treating cartilage damage in joints. Utilizing 3D printing technology and proprietary nanomaterials, the company aims to create implantable devices that replace lost or damaged cartilage and stimulate new tissue growth. This approach enables healthcare providers to offer cost-effective, on-demand treatments tailored to young and active patients suffering from knee injuries or diseases.
EeroQ is a company focused on designing quantum computer chips, specifically utilizing a novel approach that involves trapping and controlling individual electrons on superfluid helium. Founded to address the challenges in building large-scale quantum computers, EeroQ aims to advance the practical application of quantum technology through its innovative electron-on-helium architecture. This technology harnesses the purity of superfluid helium to preserve the intrinsic quantum properties of each electron, effectively creating qubits that enhance computing power delivery. Developed in collaboration with Michigan State University, EeroQ's core technology is protected by patents, positioning the company to lead advancements in the quantum computing field while also fostering discussions on ethical guidelines to ensure the technology's positive impact.
Solor
Pre Seed Round in 2024
SolOr is a supplier of techniques for creating integrated photovoltaic systems and paint based on nanomaterials. They offer photovoltaic technology, building-integrated photovoltaics technology, and quantum dots.
Ossium Health
Series C in 2023
Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.
Ion Storage Systems
Series A in 2023
Ion Storage Systems, LLC is a manufacturer of solid-state lithium-ion batteries, established in 2015 and based in College Park, Maryland. The company focuses on developing high-energy-density and safe batteries suitable for diverse applications, including defense and aerospace, consumer electronics, and electric vehicles. Ion Storage Systems has made significant advancements in solid-state battery technology, creating products that address the mission-critical needs of the defense sector while also enhancing safety and efficiency for consumer electronics and electric vehicles. Their innovative battery design features a unique structure that utilizes non-flammable materials, ensuring safety, lightness, and compactness for various applications.
EeroQ is a company focused on designing quantum computer chips, specifically utilizing a novel approach that involves trapping and controlling individual electrons on superfluid helium. Founded to address the challenges in building large-scale quantum computers, EeroQ aims to advance the practical application of quantum technology through its innovative electron-on-helium architecture. This technology harnesses the purity of superfluid helium to preserve the intrinsic quantum properties of each electron, effectively creating qubits that enhance computing power delivery. Developed in collaboration with Michigan State University, EeroQ's core technology is protected by patents, positioning the company to lead advancements in the quantum computing field while also fostering discussions on ethical guidelines to ensure the technology's positive impact.
Nanopath Inc. is a molecular diagnostics company focused on enhancing women's health through rapid and precise testing. By leveraging advancements in bioengineering and nanotechnology, Nanopath provides granular and clinically actionable information that allows for the sensitive and specific detection of viral, bacterial, and fungal pathogens. This innovative approach eliminates the need for nucleic acid amplification, thereby transforming traditional testing methodologies. The company's goal is to deliver high-quality molecular testing results in minutes, ultimately improving health outcomes for women.
Ion Storage Systems
Series A in 2022
Ion Storage Systems, LLC is a manufacturer of solid-state lithium-ion batteries, established in 2015 and based in College Park, Maryland. The company focuses on developing high-energy-density and safe batteries suitable for diverse applications, including defense and aerospace, consumer electronics, and electric vehicles. Ion Storage Systems has made significant advancements in solid-state battery technology, creating products that address the mission-critical needs of the defense sector while also enhancing safety and efficiency for consumer electronics and electric vehicles. Their innovative battery design features a unique structure that utilizes non-flammable materials, ensuring safety, lightness, and compactness for various applications.
DUST Identity
Series B in 2021
DUST Identity, Inc. specializes in developing advanced authentication technology that employs nano-diamonds to create an unclonable identity layer on various objects within supply chains. Founded in 2011 and headquartered in Framingham, Massachusetts, with an additional office in Princeton, New Jersey, the company offers a proprietary system known as DUST, which includes an optical scanner and a cloud-based infrastructure. This system provides an interface for managing object identity and provenance, ensuring that products can be verified and trusted throughout their lifecycle. By linking physical items to their digital records, DUST Identity enables businesses to access critical data regarding product sourcing, testing, and certification, thereby enhancing safety and traceability across their value chains.
Sepion Technologies
Series A in 2021
Sepion Technologies is an advanced membrane company based in Emeryville, California, founded in 2015. It specializes in the development of highly-tunable nanoscale membranes designed for various industrial applications, particularly in the energy storage sector. The company focuses on manufacturing innovative lithium-metal batteries by integrating nanoscience, polymer chemistry, and cell engineering. Its proprietary composite membrane serves as a cost-effective alternative to traditional ceramic separators used in lithium batteries, allowing for large-area production. This technology enables battery manufacturers to enhance energy density in their products, thereby improving overall performance and efficiency in energy storage solutions.
Ionobell
Seed Round in 2020
Ionobell is a battery research and development company specializing in the advancement of battery materials and cell technology. With several decades of combined expertise in energy storage, lithium-ion technology, and fabrication, Ionobell aims to create environmentally friendly batteries by utilizing abundant and unwanted materials. The company focuses on producing batteries that enhance longevity and performance while remaining cost-effective and scalable. Their innovative approach includes the use of biomaterials, common plastic waste, and recycled materials, specifically designed for applications in unmanned aerial vehicles and electric vehicles. By replacing carbon with nanoparticle silicon in the anode, Ionobell offers clients eco-friendly batteries that provide improved energy density, faster charging times, and reduced costs, all while minimizing environmental impact.
Celularity
Venture Round in 2017
Celularity is a clinical-stage biotechnology company focused on advancing cellular medicine through the development of off-the-shelf placental-derived allogeneic cell therapies. Its product pipeline includes unmodified and genetically modified natural killer (NK) cells, CAR-engineered T cells, and mesenchymal-like adherent stromal cells. The company targets various health conditions, including cancer, immunologic disorders, infectious diseases, and degenerative illnesses. Celularity leverages the unique biology of the placenta, aiming to create effective and accessible therapies to address significant unmet medical needs. In addition to its cell therapy initiatives, Celularity operates a bio-banking segment, which contributes substantially to its revenue.